Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$128,878 Mln
Revenue (TTM)
$25,116 Mln
Net Profit (TTM)
$3,246 Mln
ROE
0.2 %
ROCE
10.9 %
P/E Ratio
40.1
P/B Ratio
5.8
Industry P/E
--
EV/EBITDA
22.3
Div. Yield
1 %
Debt to Equity
0.7
Book Value
$58
EPS
$8.4
Face value
--
Shares outstanding
382,688,675
CFO
$23,728.00 Mln
EBITDA
$34,003.00 Mln
Net Profit
$19,373.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Stryker (SYK)
| -1.6 | -6.3 | -1.9 | -7.4 | 8.0 | 7.9 | 12.8 |
|
BSE Sensex
| -9.4 | -8.1 | -9.3 | 3.4 | 9.8 | 9.0 | 12.0 |
|
S&P 100
| -6.3 | -3.3 | -3.8 | 18.0 | 21.9 | 12.4 | 13.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Stryker (SYK)
| -2.4 | 20.1 | 22.5 | -8.6 | 10.2 | 18.2 | 35.3 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Stryker (SYK)
|
345.8 | 1,28,878.1 | 25,116.0 | 3,246.0 | 17.9 | 15.1 | 40.1 | 5.8 |
| 108.5 | 1,87,721.9 | 44,328.0 | 6,524.0 | 20.0 | 13.1 | 29 | 3.6 | |
| 158.1 | 57,735.4 | 21,923.0 | 1,757.0 | 12.0 | 6.9 | 26 | 1.8 | |
| 71.3 | 1,02,581.0 | 20,074.0 | 2,886.0 | 14.7 | 12.5 | 35.6 | 4.2 | |
| 191.5 | 1,32,461.4 | 24,568.0 | 3,614.0 | 18.3 | 7.1 | 37.2 | 2.9 | |
| 82.6 | 47,515.3 | 6,067.6 | 1,073.5 | 20.4 | 10.6 | 45.2 | 4.8 | |
| 577.1 | 45,820.3 | 4,303.7 | 1,059.5 | 31.7 | 66.2 | 43.9 | 28.5 | |
| 477.7 | 1,67,678.3 | 10,064.7 | 2,856.0 | 29.3 | 16.7 | 59.8 | 9.5 | |
| 227.9 | 33,694.9 | 5,398.1 | 1,485.9 | 34.0 | 24.2 | 22.8 | 5.3 | |
| 464.7 | 1,72,506.1 | 44,556.0 | 6,737.0 | 19.5 | 13.1 | 26.2 | 3.3 |
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment,... patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan. Read more
Chairman, CEO & President
Mr. Kevin A. Lobo
Chairman, CEO & President
Mr. Kevin A. Lobo
Headquarters
Portage, MI
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Stryker Corporation (SYK) is $345.81 (NYSE) as of 18-Mar-2026 16:25 EDT. Stryker Corporation (SYK) has given a return of 8.01% in the last 3 years.
The P/E ratio of Stryker Corporation (SYK) is 40.14 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
41.85
|
6.06
|
|
2024
|
46.45
|
6.74
|
|
2023
|
36.32
|
6.18
|
|
2022
|
39.64
|
5.63
|
|
2021
|
51.32
|
6.88
|
The 52-week high and low of Stryker Corporation (SYK) are Rs 404.87 and Rs 328.23 as of 19-Mar-2026.
Stryker Corporation (SYK) has a market capitalisation of $ 128,878 Mln as on 13-Mar-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Stryker Corporation (SYK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-3.30
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.